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Introduction: Prior work suggests that leukocyte trafficking is determined by local chemokine gradients between
the nidus of infection and the plasma. We recently demonstrated that therapeutic apheresis can alter immune
mediator concentrations in the plasma, protect against organ injury, and improve survival. Here we aimed to
determine whether the removal of chemokines from the plasma by apheresis in experimental peritonitis changes
chemokine gradients and subsequently enhances leukocyte localization into the infected compartment, and away
from healthy tissues.
Methods: In total, 76 male adult Sprague–Dawley rats weighing 400 g to 600 g were included in this study.
Eighteen hours after inducing sepsis by cecal ligation and puncture, we randomized these rats to apheresis or sham
treatment for 4 hours. Cytokines, chemokines, and leukocyte counts from blood, peritoneal cavity, and lung were
measured. In a separate experiment, we labeled neutrophils from septic donor animals and injected them into
either apheresis or sham-treated animals. All numeric data with normal distributions were compared with one-way
analysis of variance, and numeric data not normally distributed were compared with the Mann–Whitney U test.
Results: Apheresis significantly removed plasma cytokines and chemokines, increased peritoneal fluid-to-blood
chemokine (C-X-C motif ligand 1, ligand 2, and C-C motif ligand 2) ratios, and decreased bronchoalveolar lavage
fluid-to-blood chemokine ratios, resulting in enhanced leukocyte recruitment into the peritoneal cavity and
improved bacterial clearance, but decreased recruitment into the lung. Apheresis also reduced myeloperoxidase
activity and histologic injury in the lung, liver, and kidney. These Labeled donor neutrophils exhibited decreased
localization in the lung when infused into apheresis-treated animals.
Conclusions: Our results support the concept of chemokine gradient control of leukocyte trafficking and
demonstrate the efficacy of apheresis to target this mechanism and reduce leukocyte infiltration into the lung.* Correspondence: kellumja@upmc.edu
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Recruitment of leukocytes to the location of pathogens
is a critical step in the innate immune response to infection
[1]. Neutrophils and monocytes in particular are actors in
the complex inflammatory network that typifies sepsis
[1-4]. However, leukocyte trafficking during sepsis is al-
tered [3], and these cells (especially neutrophils and mono-
cytes) are often seen as both helpful and harmful in human
sepsis [2,4,5]. When the response to infection is contained
and controlled, pathogens are rapidly cleared, and healthy
tissues are largely spared. Conversely, widespread activa-
tion of neutrophils and monocytes leads to multiple organ
injury and failure [5-7]. Directing leukocyte recruitment to
the site of infection and away from healthy tissue can
therefore be seen as a fundamental strategy to treat sepsis.
Neutrophils and monocytes find their way to the site of
infection largely by sensing various chemical attractants.
Perhaps the most important are the chemokines clas-
sified as chemokine (C-X-C motif ) ligand 1 (CXCL1)
[8], ligand 2 (CXCL2) [9], and ligand 8 (CXCL8) [10]
for neutrophils and chemokine (C-C motif ) ligand 2
(CCL2) for monocytes [11]. Numerous studies have sug-
gested that leukocyte recruitment is dramatically influenced
by the relative proportions of these molecules between
tissue and plasma [12-16]. Within a physiologic range, as
the gradient between infected tissue and plasma increases,
leukocyte recruitment is enhanced, and pathogen clearance
is improved. Conversely, as the gradient between nonin-
fected tissue and plasma increases, inflammation and injury
to these tissues are worsened.
Recently, Craciun and colleagues [17] demonstrated
that local injection of CXCL1 and CXCL2 into the peri-
toneum after cecal ligation and puncture (CLP) resulted
in enhanced neutrophil localization, decreased bacterial
growth, and improved survival in mice. However, trans-
lation of these findings into clinical practice would be
challenging. Alternatively, it is possible to change the
chemokine gradients by reducing the plasma concentra-
tions by using apheresis. In a recent meta-analysis, blood
purification, especially hemoperfusion, significantly im-
proved the survival in patients with sepsis [18]. CytoSorb-
beads (CytoSorbents, Monmouth Junction, NJ, USA), are
composed of a novel highly adsorptive and biocompatible
polymer and have the potential to remove the multiple in-
flammatory mediators from the bloodstream. Our prior
studies have optimized the adsorptive efficacy of CytoSorb
beads and have demonstrated that therapeutic apheresis
by using a hemoadsorption (HA) device composed of
these beads could alter immune-mediator concentra-
tions in the plasma, protect against organ injury, and
improve survival [19-22]. However, acute removal of
common sepsis mediators did not explain the entire
effect of this treatment, and other mechanisms must
exist [21].Thus, we sought to alter chemokine gradients by redu-
cing the plasma concentrations by using an apheresis
system designed with CytoSorb beads in a CLP model in
the rat and to determine whether this mechanism would
result in improved leukocyte trafficking and bacterial
clearance.
Material and methods
Experimental design and study overview
Our study involved two experimental phases. In the first
experiment, we randomized animals (Groups 1 and 2) to
receive either HA or sham treatment for 4 hours begin-
ning 18 hours after CLP. We then killed animals at a
fixed time point 48 hours after treatment to collect fluid
from the abdomen and lungs and to collect tissue. Then
in the second experiment, we again randomized animals
(Groups 3 and 4) to receive either HA or sham treat-
ment for 4 hours beginning 18 hours after CLP. How-
ever, in this experiment, we obtain neutrophils from a
separate group of septic donor animals, labeled and
injected them to all animals immediately after treatment.
Finally, 24 hours later, we sacrificed animals for meas-
urement of labeled neutrophils in lung tissue. A detailed
experimental protocol is shown in Figure 1.
Animal care and surgical procedures
All animal experiments were conducted according to an
Institutional Animal Care and Use Committee of the
University of Pittsburgh (protocol 1009994) and in ad-
herence to the National Institutes of Health Guide for
the Care and Use of Laboratory Animals.
We anesthetized 76 adult (24 to 28 weeks old weight,
450 to 550 g), male, Sprague–Dawley rats with pentobar-
bital sodium (50 mg/kg intraperitoneally). We performed
a standard CLP procedure, as described previously [21],
whereby 25% of the cecum was ligated, and two punc-
tures were performed by using a 20-gauge needle. The
abdomen was then closed, and 10 ml/kg saline was given
subcutaneously as fluid resuscitation. Topical anesthetic
(lidocaine/prilocaine) was applied to the surgical wound
once immediately after the surgery to reduce the postop-
erative pain. Rats were returned to their cages and
allowed food and water ad libitum. Eighteen hours after
CLP, animals were reanesthetized with pentobarbital
sodium. The femoral vein and the internal jugular vein
were isolated by dissection and cannulated with 1.27-
mm polyethylene-90 tubing for use of extracorporeal
circulation.
Experimental protocol
Eighteen hours after CLP, animals were randomly assigned
to receive either apheresis by hemoadsorption (HA) or
sham treatment for 4 hours. The extracorporeal circulation
was driven by a mini-pump (Fisher Scientific, Pittsburgh,
Figure 1 Individual experimental groups. This study is composed of two experimental phases. In the first experiment, 18 hours after CLP,
animals (groups 1 and 2) were randomly assigned to receive either apheresis by hemoadsorption (HA) or sham treatment for 4 hours. Animals
were then killed for sampling 48 hours after treatment. In the second experiment, 18 hours after CLP, animals were randomly assigned to receive
either apheresis by HA or sham treatment for 4 hours. Labeled neutrophils from a separate group of septic donor animals were injected into all
the treated animals. At 24 hours after treatment, animals were then killed for measurement of labeled neutrophils in lung tissue.
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blood-flow rate of 0.8 to 1.0 ml/min (scaled to approxi-
mately 140 ml/min in a 70-kg human). In the HA groups,
the extracorporeal circulation passed through a 1-ml cart-
ridge containing CytoSorb polymer beads (CytoSorbents,
Monmouth Junction, NJ, USA). In the sham group, the
blood was passed through tubing with the same dead space
as the cartridge column. The extracorporeal circuit was
primed with saline containing 20 IU heparin/ml (total
volume about 2 ml). After 4 hours of therapy (or sham),
the treatment was stopped, and the rats were returned to
the animal facility, and given access to food and water.
Forty animals (n = 20 per group, groups 1 and 2) were
reanesthetized 48 hours after treatment and underwent
additional procedures as follows: First, blood was taken
for bacterial culture and chemokine measurements.
Next, 30 ml of cooled (4°C) 2.6 mM ethylenediaminetet-
raacetic acid (EDTA)-phosphate-buffered saline solution
(PBS) (0.02M, pH 7.2) was injected into the abdominal
cavity, and the abdomen was massaged for 10 minutes.
The peritoneal lavage fluid was recovered by peritoneal
puncture. The lavage fluid was then used for bacterial
culture and cytokine/chemokine measurements.
Next, 15 ml of cooled 2.6 mM EDTA-PBS was injected
into the trachea for bronchoalveolar lavage (BAL). The
aspirated peritoneal fluid and BAL fluid were then centri-
fuged at 500 g for 5 minutes. The sediments were reserved
for flow-cytometry analysis, and supernatants were collec-
ted and kept for assay of cytokines/chemokines.Finally, animals were killed, and lungs, liver, and kid-
neys were collected.
Thirty-six animals were subjected to the same CLP
procedure. Neutrophils from septic donors (one donor
for two different treated animals each time) were isolated,
labeled, and then injected into animals treated with apher-
esis or sham (groups 3 and 4; n = 12 each) immediately
after completing a course of therapy. These treated ani-
mals were then killed, and lungs were harvested the next
day. Neutrophils in the lungs were observed by using
immunofluorescence microscopy.
Chemokine/cytokine measurements and bacterial load in
compartments
Chemokines (CXCL1, CXCL2, and CCL2), and cyto-
kines, including interleukin-1 beta (IL-1β), interleukin-6
(IL-6), and tumor necrosis factor alpha (TNF-α), from
plasma, peritoneal fluid (PF), and BAL fluid were
measured with multiplex bead-based Luminex assays
(Invitrogen, Camarillo, and Affymetrix, Fremont, CA,
USA). Assays were performed by using a Bio-Rad
Bio-Plex 200 instrument and analyzed with Bio-Plex
Manager 4.0 software (Hercules, CA, USA). Blood
and peritoneal lavage fluid was serially diluted 1:10 and
plated on Tryptic Soy Agar (TSA) plates. Plates were incu-
bated for 48 hours at 37°C and 5% CO2. Colony-forming
units (CFUs) were enumerated on plates containing
30 to 300 colonies, and counts were adjusted to ori-
ginal concentration.
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Complete blood counts (white blood cells, red blood cells,
hemoglobin, hematocrit, and platelets) from central
veins were measured with an Abbott Automatic Analyzer
(Abbott Laboratory, Abbott Park, IL, USA).
Leukocyte counts with differential and leukocyte-function
tests
Leukocyte counts were performed on BAL and periton-
eal lavage fluid by using a hemocytometer. Differential
counts were performed with flow cytometry. Cells were
washed and centrifuged for 3 cycles and then stained
with PE-Cy™5 mouse anti-rat CD45 (OX-1), PE mouse
anti-rat granulocyte (RP-1), and Biotin mouse anti-rat
mononuclear followed by FITC streptavidin staining (all
from BD Pharmigen, San Diego, CA, USA). Cells were
gated on CD45. CD45 cells were analyzed for positive
expression of either the granulocyte or mononuclear
markers.
Leukocyte functions, including chemotaxis, phagocyt-
osis, and respiratory burst, were measured. The respira-
tory burst is the rapid release of reactive oxygen species
(ROS) from leukocytes and is evaluated with the release of
ROS. Neutrophils were isolated by using density gradients
and resuspended in Hank Balanced Salt Solution (HBSS).
For chemotaxis tests, a 1.5% agarose gel was created, and
three wells placed in a single line in the gel. Then 105 cells
were added to the central well, and 10 μL of 1 pmol
formyl-methionyl-leucyl-phenylalanine (FMLP) or HBSS
was added to the outer wells and incubated. Cells moving
toward each well were counted, and results expressed as a
ratio of cells moving toward the FMLP well compared
with the control well. For the phagocytosis test, 107 cells
were incubated with 108 fluorescein isothiocyanate-labeled
Pseudomonas aeruginosa (Sigma-Aldrich Co., St. Louis,
MO, USA) for 30 minutes. Cells were then fixed and mea-
sured with flow-cytometry. For ROS, 107 cells were incu-
bated with dihydroethidium for 30 minutes, before being
fixed and analyzed. Flow-cytometry samples were gated
for neutrophil size, and the mean fluorescent intensity of
the cells was measured.
Determination of neutrophil infiltration in tissues
Organs removed from groups 1 and 2 were weighed and
homogenized in lysis buffer. Cell lysates were sonicated
and centrifuged. The separated supernatant and pellet
were kept at −80°C until used. The protein concentra-
tions from supernatant and pellet were determined by
using bicinchoninic acid kit (Pierce, Rockford, IL, USA)
according to the manufacturer’s instruction. Myeloper-
oxidase (MPO) activity was measured from the pellets.
Neutrophil infiltration was assessed with MPO activity
by using a spectrophotometric method [23]. The pre-
pared tissue samples were mixed with phosphate buffercontaining o-dianisidine dihydrochloride and hydrogen
peroxidase. One unit of peroxidase activity was defined
as the amount of enzyme decomposing 1 μmol hydrogen
peroxidase per minute at 25°C. Decomposition of hydro-
gen peroxide was calculated from the oxidation of o-dia-
nisidine by using an absorption coefficient of 11.3 L/mol
per cm at 460 nm. MPO was presented as U/ml/mg
tissue protein.
In vivo labeling of leukocytes and evaluation of the
trafficking of these labeled leukocytes
Neutrophils were isolated by using density gradients. Neu-
trophil purity was >85%. Isolated neutrophils were stained
with Cell Tracker Red [24] (Invitrogen) according to the
manufacturer’s instructions. Labeled cells were injected
into animals immediately after apheresis or sham treat-
ment. Twenty-four hours after injection of labeled neutro-
phils, animals were killed, and lungs inflated and fixed in
2% PFA for 4 hours at 4°C. After fixation, lungs were
transferred to 30% sucrose solution overnight at 4°C. The
samples were then frozen by using liquid nitrogen along
with 2-methylbutane and stored at −80°C. The lungs were
cryosectioned on a cryostat, Micron model HM550 at 7
microns thickness. Next the slides were stained with 647
Cy5 phalloidin markers to label the actin and Hoechst
nuclear stain to label the nucleus. Slides were coverslipped
using Gelvatol and stored at 4°C to dry overnight.
Ten sections were placed onto slides and stained with
4',6-diamidino-2-phenylindole (DAPI). The sections
were chosen at random during the staining process.
Slides were evaluated using 10 field views per slide total-
ing 100 field views per animal. Field views were selected
using a zig-zag pattern through the tissue. Areas of large
spaces were avoided and fields were excluded if they
crossed an exterior border of the lung. Pictures were taken
using an Olympus upright epi fluorescence microscope
(model BX51, Olympus Imaging America, Center Valley,
PA) and analyzed by a researcher (J-E, D) blinded to the
animal treatment state using software of MagnaFire
version 2.1 (Optronics, Goleta, CA).
Histology
Liver and kidney sections were fixed in 10% neutral buff-
ered formalin, dehydrated in graded anhydrous absolute
ethanol, and embedded in paraffin. Lungs were inflated
and fixed with Zinc Fixative (BD Pharmingen, San Diego,
CA). Histological sections (5 μm) were stained with
hematoxylin, eosin and periodic acid Schiff. The histology
was assessed by a pathologist (X-Y, W) blinded to the
intervention.
Ex-vivo bacterial adsorption
Escherichia coli (E. coli, Sigma-Aldrich Co., St Louis, MO)
were reconstituted with Bacto Tryptic Soy Broth (TSB)
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every 15 minutes until desired E. coli concentration was
achieved. The E. coli suspension was diluted 1:25000, and
7 mL of the dilution added to a 15 mL conical tube. A
sterilized closed circuit containing the column with theFigure 2 Effects of apheresis on cytokines and chemokines in differen
natural log transformed, n = 14 to 18 each). Eighteen hours after CLP, a
hemoadsorption (HA) or sham treatment for 4 hours. Animals were then ki
among blood, peritoneal fluid (PF), and bronchoalveolar lavage fluid (BAL)
and (F) IL-6. Tx, treatment. “Before Tx” is the time point when samples werCytoSorb polymer beads (HA) or empty column (sham)
through the conical tube (reservoir) was set up. The flow
rate was controlled at 0.8 ml/min with the mini-pump. 50
uL of duplicate samples from pre-column, post-column
and reservoir were collected before circulation, and 2 andt compartments (data are expressed as mean ± SE after being
nimals were randomly assigned to receive either apheresis by
lled for sampling 48 hours after treatment. Shown are the comparisons
after treatments. (A) CXCL1; (B) CXCL2; (C) CCL2; (D) IL-1β; (E) TNF-α;
e obtained at 18 hours after CLP but before initiation of apheresis.
Figure 3 Effects of apheresis on the ratios of local to systemic
chemokine concentrations (mean ± SE, n = 14 to 18 each).
Eighteen hours after CLP, animals were randomly assigned to
receive either apheresis by hemoadsorption (HA) or sham
treatment for 4 hours. Animals were then killed for sampling
48 hours after treatment. Shown are peritoneal fluid (PF)-to-blood
and bronchoalveolar lavage fluid (BAL)-to-blood ratios for (A) CXCL1;
(B) CXCL2; and (C) CCL2.
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on agar plates and allowed to incubate at 37°C. The CFUs
were counted the following morning.
Statistical analyses
Numeric data not normally distributed were expressed as
median and range, natural log transformed, and compared
with Mann–Whitney U test. All numeric data with nor-
mal distribution (including cytokine and chemokine data
after natural log transformation) were expressed as mean
± standard error (SE), and compared with one-way ana-
lysis of variance and the post hoc Student-Neuman-Keuls
test. All analyses were performed by using SPSS statistical
software package (SPSS for Windows; Chicago, IL, USA).
P values below 0.05 were considered to be statistically
significant.
Results
Apheresis changed the cytokine and chemokine levels in
different compartments and altered the ratios of local to
systemic chemokine concentrations
Cytokines (IL-1β, TNF-α, and IL-6) and chemokines
(CXCL1, CXCL2, and CCL2) in plasma and lung were sig-
nificantly decreased with apheresis (Figure 2; P < 0.05).
Apheresis also increased chemokines (CXCL1, CXCL2,
and CCL2) in the peritoneal cavity (Figure 2; P < 0.05).
Compared with sham, apheresis treatment significantly
increased the ratios of chemokines from peritoneal fluid
to circulating plasma: CXCL1 (8.51 versus 1.65; P < 0.01,
Figure 3A), CXCL2 (7.17 versus 2.32; P = 0.02, Figure 3B)
and CCL2 (3.56 versus 1.69; P = 0.02; Figure 3C). It is im-
portant that, compared with sham, apheresis also signifi-
cantly decreased the ratios of BAL to plasma chemokines:
CXCL1 (0.52 versus 2.37; P = 0.04; Figure 3A), CXCL2
(0.94 versus 1.69, P = 0.03; Figure 3B) and CCL2 (0.27
versus. 1.82; P = 0.01; Figure 3C).
Apheresis redirected leukocyte trafficking into different
compartments and improved bacterial clearance from the
peritoneal cavity
To determine whether modulation of chemokine gra-
dients resulted in changes in leukocyte trafficking, we
then measured the number of leukocytes in the peri-
toneum and lungs. Figure 4 shows that peritoneal
fluid from apheresis-treated animals contained more
neutrophils as compared with that from sham-treated
animals (4.0 × 106/ml versus 0.97 × 106/ml; P = 0.03;
Figure 4A) and more monocytes (2.2 × 106/ml versus
0.36 × 106/ml; P = 0.02, Figure 4B). In contrast to the
changes in the peritoneal cavity, fewer neutrophils (1.16 ×
105/ml apheresis versus 4.0 × 105/ml sham; P = 0.01;
Figure 4C) were in the lungs after apheresis treat-
ment. However, no significant difference was found in
monocytes in the lungs between the apheresis and
Figure 4 Effects of apheresis on leukocyte influx into the peritoneal cavity and lung. Eighteen hours after CLP, animals were randomly
assigned to receive either apheresis by HA or sham treatment for 4 hours. Animals were then killed for sampling 48 hours after treatment. Cells
were washed and centrifuged for three cycles and then stained with PE-Cy5 mouse anti-rat CD45 (OX-1), PE mouse anti-rat granulocyte (RP-1)
and Biotin mouse anti-rat mononuclear followed by FITC streptavidin staining. Cells were gated on CD45. CD45 cells were analyzed for positive
expression of either the granulocyte or mononuclear markers. Shown are (A) neutrophils; and (B) monocytes in the peritoneal cavity; (C) neutrophils
and (D) monocytes in the lung. Comparisons are between apheresis (HA) and sham. Medians and ranges of cells per milliliter (natural log transformed,
n = 14 to 18 each) are shown.
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P = 0.35; Figure 4D).
To investigate whether apheresis directly altered neu-
trophil function, we measured chemotaxis, phagocytosis,
and oxidative burst. No differences were found in PMN
oxidative burst or in other measures in neutrophils taken
from animals treated with apheresis versus sham (Figure 5).
Apheresis also resulted in less bacterial growth from the
peritoneal fluid (6.05 × 106cfu/ml versus 52.15 × 106cfu/ml;
P = 0.04; Figure 6A). Apheresis did not alter white blood
cell or platelet counts (Table 1). In addition, no bleeding-
related adverse events were found.
Apheresis did not adsorb the bacteria directly
To explore where the improved bacterial clearance by
the apheresis is to the result of the increased leukocyte
trafficking or direct adsorption, we ran an ex vivo bacterial
adsorption experiment. After 2 and 4 hours, no significant
differences were found in bacterial loads between the pre-and postcolumn with beads (60.58 × 106 versus 61.38 × 106
at 2 hours and 224.40 × 106 versus 222.00 × 106 at 4 hours;
P > 0.05; Table 2). Moreover, the bacterial loads in the
reservoirs between the sham and apheresis at 2 hours
(51.20 × 106 versus 54.75 × 106; P = 0.97) and 4 hours of
circulation (241.70 × 106 versus 218.20 × 106; P = 0.56)
were not different (Table 3).
Apheresis attenuated remote organ neutrophil infiltration
and histologic injury
Animals treated with apheresis also exhibited significantly
attenuated MPO activity in the lungs (0.80 versus 1.95 U/
ml/g; P = 0.01, Figure 6B), liver (0.78 versus 2.03 U/ml/g,
P = 0.02, Figure 6B) and kidney (0.47 versus 0.98 U/ml/g,
P = 0.04, Figure 6B) compared with the sham-treated ani-
mals. Finally, the severity of histopathology (lung, liver,
and kidney), although mild overall, was consistent with
the MPO results (Figure 6C, D, and E). Sham showed neu-
trophil infiltration and hemorrhage in lungs, but these
Figure 5 Effects of apheresis on PMN function (median and
ranges, n = 7). Eighteen hours after CLP, animals were randomly
assigned to receive either apheresis by HA or sham treatment for
4 hours. Animals were then killed for sampling 48 hours after
treatment. (A) PMN chemotaxis expressed as ratio (percentage) of
cells migrating toward chemoattractant to cells migrating away
from chemoattractant. (B) PMN phagocytosis expressed as mean
fluorescent intensity (MFI). (C) PMN oxidative burst (ROS) expressed
as mean fluorescent intensity (MFI).
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sham treatment, apheresis showed less swelling of hepato-
cytes and necrosis and resulted in less vacuolization in
renal tubules compared with sham.Apheresis redirected neutrophils from septic donors away
from the lungs
Finally, fewer labeled donor neutrophils were seen in
lungs taken from apheresis-treated CLP animals compared
with sham (37 cells in apheresis versus 88 cells in sham per
high-power field, n = 12, P = 0.03, Figure 7). These results
suggest that the decreased neutrophil infiltration into the
lungs was due to chemokine gradient differences between
groups as a result of apheresis rather than direct effects on
the cells.
Discussion
In this study, we demonstrated that a single 4-hour
application of a novel apheresis system removed cyto-
kines and chemokines from plasma, reduced cytokines
and chemokines in the lung, and increased chemokines
in the peritoneal cavity. Chemokine removal from the
plasma compartment by using this technique resulted in
increased chemokine gradients between the peritoneal
cavity and the plasma; increased leukocyte recruitment
into peritoneal space; and decreased bacterial counts in
the peritoneal fluid at 48 hours after treatment. Further-
more, we found that chemokine gradients were reversed
in the lung (a decreased gradient with active treatment
compared with sham), and neutrophil infiltration into
the lung was also decreased. Finally, we established that
these changes in leukocyte trafficking resulted from
changes in the plasma (presumably alterations in chemo-
kine or other mediators) rather than from direct action
on the cells themselves. Indeed, donor neutrophils naïve
to the intervention exhibited decreased lung infiltration
when injected into apheresis-treated animals, although
neutrophil function itself was not enhanced by the treat-
ment, as evidenced by lack of change in phagocytosis or
bacterial killing.
We used CLP-induced sepsis to test our device in this
study because it resembles clinical sepsis [20,21]. The
peritonitis that ensues is polymicrobial (for example,
Escherichia coli, Proteus mirabilis, Enterococcus sp.,
Bacteroides fragilis, and so on) and resembles human
disease. We chose CXCL1, CXCL2, and CCL2 as the
target chemokines, as these markers represent common
chemokines necessary to regulate leukocyte trafficking in
rats. These markers are easily detected in this model
(CXCL8 not produced by rodents). We started treatment
at 18 hours after CLP, as the concentrations of most medi-
ators reach peak levels and the ligated cecum begins to
heal after 24 hours [21]. We killed animals for PF and
BAL samples at 48 hours after treatments, as our previous
study [21] showed that the significant changes in organ
function, as well as cytokines/biomarkers, occurred at
48 hours after treatment.
Our results extend the findings of prior studies from
our laboratory [19-21] and others [12-16,25,26]. Prior
Figure 6 Effects of apheresis on the bacterial clearance, neutrophil infiltration, and histopathology. Eighteen hours after CLP, animals
were randomly assigned to receive either apheresis (HA) or sham treatment for 4 hours. Animals were then killed for sampling 48 hours after
treatment. (A) Bacterial load in the peritoneal fluid (PF) (medians and ranges for colony-forming units per milliliter (natural log transformed, n = 12
to 16 each). (B) Myeloperoxidase (MPO) activity (mean ± SE, U/ml/mg; n = 20 each). *P < 0.05, apheresis (HA) versus sham in lung, liver, and kidney.
(C) Lung histology (n = 4 to 6 each). Sham showed neutrophil infiltration and hemorrhage not seen with apheresis (HA). (D) Liver histology
(n = 4 to 6 each). Apheresis (HA) showed milder swelling of hepatocytes and necrosis compared with sham. (E) Kidney histology (n = 4 to 6 each).
Apheresis (HA) resulted in less vacuolization in tubules compared with sham.
Table 1 Effects of apheresis on complete blood cells (n = 6, mean and SE)
Before apheresis After 4-hour apheresis P values
HA Sham HA Sham
RBC (×1012/L) 3.92 ± 0.18 3.75 ± 0.36 3.88 ± 0.17 3.83 ± 0.31 0.881 0.892
WBC (×109/L) 8.38 ± 0.70 8.17 ± 0.48 7.17 ± 0.57 8.73 ± 0.53 0.211 0.092
Platelets (×109/L) 371 ± 39 341 ± 29 290 ± 32 336 ± 32 0.111 0.332
HA, apheresis by hemoadsorption; Sham, sham treatment; RBC, red blood cell; WBC, white blood cell.
1: before values versus after values in HA group; 2: HA versus Sham after treatments.
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Table 2 Effects of apheresis on ex vivo bacterial removal (n = 6, mean and SE); Changes in bacterial load between pre-
and post-columns after 2- and 4-hour apheresis
After 2-hour apheresis (×106 CFU/ml) After 4-hour apheresis (×106 CFU/ml) P
values1Pre-columns Post-columns Pre-columns Post-columns
Sham 79.68 ± 13.88 73.43 ± 14.52 267.60 ± 35.63 260.70 ± 38.06 0.76; 0.90
HA 60.58 ± 4.27 61.38 ± 6.21 222.40 ± 11.60 222.00 ± 20.65 0.92; 0.99
P values2 0.22 0.46 0.26 0.39
HA, apheresis by hemoadsorption; Sham, sham treatment.
1: Precolumn values versus postcolumn values at the same time; 2HA versus Sham.
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http://ccforum.com/content/18/4/R141studies found that leukocyte trafficking is highly depen-
dent on cytokine and especially chemokine gradients
from the nidus of infection to the circulation [12-16].
Similar to our results, Craciun and colleagues [17] found
that increasing these gradients (by direct infusion of che-
mokines) enhanced neutrophil localization, decreased
bacterial growth, and improved survival.
Our prior studies using apheresis as a treatment for
sepsis demonstrated improved survival and organ pro-
tection [19-21,27] but attempts to understand these
effects by using systems modeling revealed that changes
in cytokines alone were inadequate to explain the effects
on survival [28]. As we scaled back our treatment inten-
sity to a level easily applicable to humans, we found that
the effects on circulating cytokines were delayed (by up
to 48 hours), even though survival was still improved
and appeared to be the result of fewer activated leu-
kocytes in the circulation after therapy [21]. We can
now understand these results by observing changes in
leukocyte trafficking as a result of apheresis.
Our results are also consistent with an emerging
“general model” of sepsis [20,21], which helps explain
a number of seemingly conflicting results from clinical
and laboratory studies. First, Alves-Filho et al. [29] dem-
onstrated that a lethal model of CLP-induced sepsis was
associated with less neutrophil recruitment into the peri-
toneal space compared with a sublethal model, despite less
systemic inflammation. Studies in older animals [30,31]
also demonstrated that despite greater systemic innate
immune system activation, worse bacterial clearance oc-
curred compared with younger animals given the same
inoculum. Similarly, in the largest study of its kind to date
[32], we found that greater cytokine activity in the plasma
(regardless of the cytokine measured) was associated
with worse survival in humans with community-acquiredTable 3 Effects of apheresis on ex vivo bacterial removal (n =
reservoir after 2- and 4-hour apheresis
Before apheresis (CFU/ml) After 2-o
Sham 9.15 × 106 ± 1.68 × 106 51.20 × 10
HA 8.85 × 106 ± 1.31 × 106 50.75 × 10
P values 0.89 0.97
HA, apheresis by hemoadsorption; Sham, sham treatment.pneumonia. The worst survival overall was seen in pa-
tients with high levels of both pro- and antiinflammatory
cytokines.
Finally, a growing body of evidence indicates the pres-
ence of immune-system incompetence in the setting of
sepsis despite increased immune system activation [33-36].
What emerges from these diverse findings is a model in
which severe local inflammation becomes systemic and
leads to uncontrolled immune activation or “spillage” of
inflammation to other compartments, thereby disrupting
the signal-to-noise relation on which chemokine signaling
depends [35,37]. Moreover, once cells are activated in the
periphery, they can adhere to similarly activated endo-
thelium and infiltrate into otherwise healthy tissues. Once
there, these cells can further stimulate neutrophil recruit-
ment by means of producing chemokines, and perpetuate
inflammation and tissue injury [35,37]. Our results show
that this process is reversible, leading to reduced organ
infiltration and attenuated tissue injury (Figures 6 and 7).
We note the impact of computational modeling in pointing
out the key role of dysregulated trafficking in sepsis patho-
physiology [38], focusing our experimental design on the
neutrophil response within a limited time window of
intervention. Further insights from modeling pertaining to
neutrophil phenotypic evolution during sepsis are the
focus of ongoing experimental work.
Our investigation has limitations. We elected to con-
duct these experiments by using a model of sepsis with-
out antibiotics. However, the frequent lack of prehospital
antibiotic administration, along with the delays and/or
inappropriate use of antibiotics during early hospitali-
zation, make this design relevant. It is also true that sepsis
frequently occurs in settings in which organisms are re-
sistant to first-line (or in some cases all) antibiotics, and
thus our model has direct relevance to an important6, mean and SE); Changes in bacterial loads in the
ur apheresis (CFU/ml) After 4-hour apheresis (CFU/ml)
6 ± 9.85 × 106 241.70 × 106 ± 35.09 × 106
6 ± 5.09 × 106 218.20 × 106 ± 17.25 × 106
0.56
Figure 7 Effects of apheresis on neutrophil influx into the lungs. Eighteen hours after CLP, animals were randomly assigned to receive either
apheresis (HA) or sham treatment for 4 hours. Labeled neutrophils from septic donor animals were injected after treatment into (A) HA and (B)
sham-treated animals (n = 12 each). Neutrophils in the lungs (red color, and arrows) were observed after 24 hours with immunofluorescence
microscopy (20× magnifications). (C) Comparison of labeled neutrophils infiltrated in the lung between HA and sham-treated septic animals
(data expressed as medians and ranges after natural log transformation). Fewer neutrophils were seen in the lungs of HA-treated animals (A)
compared with sham (B).
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http://ccforum.com/content/18/4/R141clinical problem. We measured only three important che-
mokines (CXCL1, CXCL2, and CCL2). The roles of other
neutrophil chemoattractants such as complement frag-
ments or leukotrienes were not considered in this study.
Neither did we evaluate whether bone marrow production
of neutrophils was altered by the therapy. Given the
small-animal model, we could not perform repeated sam-
pling from the peritoneal cavity and BAL fluid, and could
obtain these samples at only one time point (48 hours
after treatment) with the death of the animal. We also lack
enough evidence to explain how apheresis decreased the
chemokine gradients of lung to circulation (blood). It
seems more likely that apheresis decreases the levels
of pro-inflammatory cytokines (IL-1β, TNF-α, and IL-6;
Figure 2D-F), which then results in decreased chemokineproduction in the lung (Figure 2A-C) and subsequently
decreases lung/blood ratio.
Another possibility is that apheresis decreased circulating
white blood cells. Our prior ex vivo work demonstrated
that apheresis adsorbs activated PMNs and monocytes
[39]. However, our in vivo results do not demonstrate a
significant effect on circulating cells (Table 1), and our final
experiment used cells naïve to the treatment, taken from
untreated donors (Figure 7).
Conclusion
A novel apheresis device using specific adsorptive bio-
materials can effectively restore chemokine gradients
toward infected tissue and away from healthy organs
in an experimental model of polymicrobial abdominal
Peng et al. Critical Care 2014, 18:R141 Page 12 of 13
http://ccforum.com/content/18/4/R141sepsis. These results should set the stage for future
clinical trials.
Key messages
 Apheresis with specific adsorptive biomaterials can
restore chemokine gradients toward infected tissue
and away from healthy organs.
 This study supports the concept of chemokine
gradient control of leukocyte trafficking and may
help explain some of the beneficial effects of this
apheresis technology.
 Further studies are needed to explain how apheresis
decreases the chemokine gradients of lung to
circulation.
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